News & Articles
Selected Filters:
Cancer immunotherapies: How single-cell sequencing can aid informed decision-making
An insider’s view on leveraging the latest single-cell technologies, including cell sorting and single-cell sequencing, to understand what drives response or resistance in checkpoint therapies
SelectScience wins 2021 Queen’s Award for Enterprise
Team dedicates the award to the scientists, healthcare professionals and scientific manufacturers who have risen to the challenges of the pandemic
CardiNor has secured NOK12 million (US$1.46M) to commercialize first secretoneurin ELISA test
The growing heart failure pandemic increases need for new innovative assays
Keeping up with COVID-19: Designing novel monitoring assays to tackle the rise of variants
Dr. Tania Nolan outlines how her team is designing assays to identify new variants and why these are critical to managing the global response
3D Cell Culture: Patient mini-brains, cancer insights, drug screening and more
Keep up to date with the latest research and discover the tools and techniques advancing 3D cell culture and its applications
Bio-Techne has announced the commercial release of novel DNAscope in situ hybridization assays
Pushing the spatial genomics frontier one biomolecule at a time from RNA to DNA
Dispensing cells in nanoliter volumes onto Droplet Microarrays: dramatic reduction of material costs for cell screenings
In this guest editorial, Fritz Gyger AG shares how the revolutionary Droplet Microarray provides a solution to the limitations currently faced when using traditional microplates
Paragon Genomics highlights year of rapid growth fueled by broad acceptance of its CleanPlex SARS-CoV-2 research and surveillance products
The new emerging variant panel add-on for use with existing CleanPlex SARS-CoV-2 products allows researchers to easily maintain confident variant identification as the virus evolves
Avacta receives clinical validation of AffiDX SARS-CoV-2 antigen lateral flow test
The test offers 98.0% clinical sensitivity for samples with PCR Ct values up to 31
5 expert webinars coming up this week
Explore topics from AAV gene therapy and food fraud advances to LC-MS and Raman spectroscopy for drug discovery
Roche receives FDA approval for first companion diagnostic to identify endometrial cancer patients eligible for immunotherapy
VENTANA MMR RxDx Panel is the first immunohistochemistry predictive test in endometrial cancer for treatment with the anti-PD1 immunotherapy JEMPERLI
Bio-Rad has launched SARS-CoV-2 Variant RT-PCR Assays
The assays will help public health researchers track SARS-CoV-2 variants more rapidly and cost-effectively